AAV-Vectored Expression of the Vascular Normalizing Agents 3TSR and Fc3TSR, and the Anti-Angiogenic Bevacizumab Extends Survival in a Murine Model of End-Stage Epithelial Ovarian Carcinoma

Ashley A. Stegelmeier(University of Guelph), Sarah K. Wootton(University of Guelph)
Biomedicines
February 2, 2022
Cited by 8


Related Papers